Leber hereditary optic neuropathy

Last revised by Rohit Sharma on 29 Mar 2024

Leber hereditary optic neuropathy (LHON) is a mitochondrial genetic disorder characterized by bilateral, progressive, central vision loss secondary to loss of the retinal ganglionic cell layer 1,2.

Leber hereditary optic neuropathy classically presents in young, Caucasian, adult men aged 14-26 years, with worldwide prevalence estimated at 1:50,000 3. Approximately 10% of patients report symptom onset after the age of 50 4.

Symptom onset typically involves unilateral blurred vision, with the majority of cases sequentially affecting the contralateral eye at a median delay of eight weeks. Simultaneous vision impairment has also been described in 25% of patients 5. One week after symptom onset, the most common visual field defects are central or paracentral scotoma. Six months after onset, diffuse visual field defects are more common 6. Fundoscopy may reveal telangiectasias, although negative fundoscopy findings do not exclude Leber hereditary optic neuropathy 7.

Additional clinical features may also be present, encompassing what has been described as an 'LHON plus' phenotype 17-19:

  • movement disorders: dystonia, tremor

  • peripheral neuropathy

  • multiple sclerosis-like illness

  • ataxia

  • cardiac conduction anomalies and arrhythmias

Leber hereditary optic neuropathy is caused by mitochondrial DNA (mtDNA) mutation coding for enzyme Complex I, a key component of the electron transport chain 17. The majority of the cases being homoplasmic (all inherited mtDNA contains the mutation) 17. Only 10-15% of Leber hereditary optic neuropathy mutations are heteroplasmic 17. Being due to an mtDNA mutation, this condition is maternally inherited 17. Up to 60% of patients with Leber hereditary optic neuropathy will endorse a positive maternal history as de novo mutation is rare 16.

Classically, MRI findings in Leber hereditary optic neuropathy have been described as resembling multiple sclerosis 8,9. However, other features may be present across the visual system. In one study in patients less than 12 months since symptom onset, bilateral T2 hyperintensity in the posterior optic nerves and optic chiasm with associated T2 white matter lesions not resembling multiple sclerosis 10. Patients may also present with decreased volume of the optic chiasm, optic tract and primary visual cortex 11,12. Patients may also have increased volume of the bilateral lateral ventricles, third ventricle, and fourth ventricle 12.

Whilst there is no current treatment to improve the visual effects of Leber hereditary optic neuropathy, idebenone, vitamin B2 and vitamin C supplementation has been described to improve visual recovery in one study 13. In most patients, visual dysfunction is permanent. Spontaneous recovery may rarely occur in some patients and is associated with mutational status and younger age of symptom onset 14.

To prevent visual loss, mutation carriers should be counseled on smoking cessation and reduction of alcohol consumption 15,17.

Leber hereditary optic neuropathy may be diagnosed clinically, however, the differential diagnosis should include other causes of optic neuropathy, such as compressive optic neuropathy, optic neuritis, and toxic optic neuropathy.

ADVERTISEMENT: Supporters see fewer/no ads

Updating… Please wait.

 Unable to process the form. Check for errors and try again.

 Thank you for updating your details.